We’re delighted to be attending Genesis 2018 again and hosting our own panel session over lunch.
'Applying AI in drug development and discovery'
Machine learning and other technologies are expected to make the hunt for new pharmaceuticals quicker, cheaper and more effective. In today's digital economy, digitisation has become a vital way to build competitive differentiation in an increasingly competitive market. Artificial intelligence has a projected market value in drug discovery expected to reach $4 billion by 2024.
Chair: Dr Chris Doherty, Managing Director, Alderley Park
James Peach, Precision Medicine Lead, Medicines Discovery Catapult
Anthony D. Bashall, Managing Director, Zenzium
Dr Alexander G. Dossetter - Managing Director MedChemica Limited
If you’d like to set up a meeting with the team, please contact us by emailing firstname.lastname@example.org.